84 related articles for article (PubMed ID: 8442268)
1. Implications of lymphocyte sensitivity to glucocorticoids in renal transplant recipients.
Kozaki M; Hirano T; Oka K; Sakurai E; Tamaki T; Tanaka M; Kono K; Matsuno N; Uchiyama M; Kozaki K
Transplant Proc; 1993 Feb; 25(1 Pt 2):921-3. PubMed ID: 8442268
[No Abstract] [Full Text] [Related]
2. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
[No Abstract] [Full Text] [Related]
3. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
4. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
Nomura Y; Tomikawa S; Beck Y; Nishimura Y; Meigata K; Ando Y; Kikuchi K
Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
[No Abstract] [Full Text] [Related]
5. Donor-specific blood transfusion in living-related renal transplantation: fourteen-year experience.
Okazaki H; Sato T; Miura S; Amada N
Transplant Proc; 1997; 29(1-2):200-2. PubMed ID: 9122962
[No Abstract] [Full Text] [Related]
6. Soluble IL-2R assay and spontaneous blastogenesis in the immunological monitoring of kidney transplant patients.
de Boccardo G; Albano S; Alvarellos T; Massari P; Giraudo C
Transplant Proc; 1994 Oct; 26(5):2854-6. PubMed ID: 7940899
[No Abstract] [Full Text] [Related]
7. Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
Takahara S; Moutabarrik A; Kokado Y; Kameoka H; Takano Y; Zaid D; Ishibashi M; Sonoda T; Okuyama A
Transplant Proc; 1993 Jun; 25(3):2254-8. PubMed ID: 8516891
[No Abstract] [Full Text] [Related]
8. Influence of clinical immunosuppression on proinflammatory cytokines and acute-phase proteins.
Semenkov VF; Artemjeva OV; Shishina RN; Golubeva VL; Serova LD
Transplant Proc; 1998 Dec; 30(8):4195. PubMed ID: 9865345
[No Abstract] [Full Text] [Related]
9. Comparative efficacy of prophylactic monoclonal (OKT3) and polyclonal antibodies (ATG) in immunologic high-risk renal transplant recipients.
Fukuuchi F; Lefrançois N; Chapuis F; Gebuhrer L; Bosshard S; Dubernard JM; Touraine JL
Transplant Proc; 1996 Oct; 28(5):2808-9. PubMed ID: 8908070
[No Abstract] [Full Text] [Related]
10. Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man.
Ohlman S; Gannedahl G; Tydén G; Tufveson G; Groth CG
Transplant Proc; 1992 Feb; 24(1):318-20. PubMed ID: 1539294
[No Abstract] [Full Text] [Related]
11. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
Sakhuja V; Sharma UK; Jha V; Minz M; Chugh KS
Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
[No Abstract] [Full Text] [Related]
12. Triple versus quadruple induction immunosuppression in pancreas transplantation.
Wadström J; Brekke B; Wramner L; Ekberg H; Tydén G
Transplant Proc; 1995 Feb; 27(1):1317-8. PubMed ID: 7878896
[No Abstract] [Full Text] [Related]
13. Degree and sequential change of peripheral blood microchimerism in renal transplant recipients.
Aikawa A; Yamashita M; Arai K; Hirayama N; Ohara T; Hasegawa A; Kaneshige T; Hirai H
Transplant Proc; 1996 Jun; 28(3):1288-90. PubMed ID: 8658663
[No Abstract] [Full Text] [Related]
14. Lymphocyte suppression by glucocorticoids with cyclosporine, tacrolimus, pentoxifylline, and mycophenolic acid.
Briggs WA; Eustace J; Gimenez LF; Choi MJ; Scheel PJ; Burdick JF
J Clin Pharmacol; 1999 Feb; 39(2):125-30. PubMed ID: 11563403
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of donor sensitization in kidney transplant recipients by flow cytometric crossmatch.
Cinti P; Bachetoni A; Baiano V; Pretagostini R; Poli L; Berloco P; Renna Molajoni E; Cortesini R
Transplant Proc; 1993 Dec; 25(6):3265-6. PubMed ID: 8266536
[No Abstract] [Full Text] [Related]
16. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Wieneke H; Otte B; Lang D; Heidenreich S
Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
[TBL] [Abstract][Full Text] [Related]
17. Low level of interleukin 10 synthesis during liver allograft rejection.
Conti F; Boulland ML; Leroy-Viard K; Chereau C; Dousset B; Soubrane O; Weill B; Calmus Y
Lab Invest; 1998 Oct; 78(10):1281-9. PubMed ID: 9800954
[TBL] [Abstract][Full Text] [Related]
18. Is trauma associated with acute rejection of a renal transplant?
Mohammed EP; Venkat-Raman G; Marley N
Nephrol Dial Transplant; 2002 Feb; 17(2):283-4. PubMed ID: 11812881
[No Abstract] [Full Text] [Related]
19. Noninvasive monitoring of rejection therapy based on intramyocardial electrograms after orthotopic heart transplantation.
Grasser B; Schreier G; Iberer F; Wasler A; Petutschnigg B; Müller H; Prenner G; Hipmair G; Hutten H; Schaldach M; Tscheliessnigg KH
Transplant Proc; 1996 Dec; 28(6):3276-7. PubMed ID: 8962272
[No Abstract] [Full Text] [Related]
20. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
